Ligand · ULV
ULV · 4-{8-amino-3-[(6r,8as)-3-oxohexahydro-3H-[1, 3]oxazolo[3,4-a]pyridin-6-yl]imidazo[1,5-a]pyrazin-1-yl}-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide
ULV, 4-{8-amino-3-[(6r,8as)-3-oxohexahydro-3H-[1, 3]oxazolo[3,4-a]pyridin-6-yl]imidazo[1,5-a]pyrazin-1-yl}-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide (C26 H22 F3 N7 O3, 537.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2…
- Component
- ULV
- Formula
- C26 H22 F3 N7 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
ULV in 2 structures; the first of them:
- 6X3N · Co-structure of BTK kinase domain with L-005085737 inhibitor · ULV A701 · binds LEU408, GLY409, THR410, GLY411, VAL416, ALA428, LYS430, ILE432 and 15 more
- 6X3N · Co-structure of btk kinase domain with L-005085737 inhibitor · ULV A701 · binds LEU408, VAL416, ALA428, LYS430, ILE432, GLU445, MET449, ILE472 and 11 more
Residues it binds most
LEU 2, GLU 2, GLY 2, ILE 2, MET 2, THR 2, VAL 2, ALA 2, ASN 2, ASP 2 (residue and the binding sites it lines).
Found with
- 5WE · 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino) butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.